Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Wilkinson

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Cell Host & Microbe|May 19, 2023
Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary diseaseWeijie Liang, Yuqiong Yang, Shenhai Gong, et al.
Thorax|February 2, 2018
Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbationsDavid Mayhew, Nathalie Devos, Christophe Lambert, et al.
Respiratory Research|January 30, 2025
NTHi killing activity is reduced in COPD patients and is associated with a differential microbiomeVancheswaran Gopalakrishnan, Ben Sparklin, Jung Hwan Kim, et al.
ERJ Open Research|May 25, 2023
Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPDVentzislava A Hristova, Alastair Watson, Raghothama Chaerkady, et al.
ACS Central Science|June 1, 2022
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 InteractionScott E Guimond, Courtney J Mycroft-West, Neha S Gandhi, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Cell Host & Microbe|May 19, 2023
Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary diseaseWeijie Liang, Yuqiong Yang, Shenhai Gong, et al.
Thorax|February 2, 2018
Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbationsDavid Mayhew, Nathalie Devos, Christophe Lambert, et al.
Respiratory Research|January 30, 2025
NTHi killing activity is reduced in COPD patients and is associated with a differential microbiomeVancheswaran Gopalakrishnan, Ben Sparklin, Jung Hwan Kim, et al.
ERJ Open Research|May 25, 2023
Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPDVentzislava A Hristova, Alastair Watson, Raghothama Chaerkady, et al.
ACS Central Science|June 1, 2022
Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike-ACE2 InteractionScott E Guimond, Courtney J Mycroft-West, Neha S Gandhi, et al.
Pageof 12